This study investigates the safety and effectiveness of Adaptive Radiation Therapy (ART) for treating locally advanced pancreatic cancer.
The study evaluates how well ART targets aggressive cancer cells while protecting healthy tissue, and whether it reduces treatment side effects.
- Who can participate: Adults aged 18 and older with locally advanced unresectable pancreatic cancer may participate. Key eligibility includes confirmed pancreatic cancer and adequate organ function.
- Study details: Participants will undergo CT scans and may have markers placed near the tumor for planning. They will receive five radiation treatments, and blood samples will be collected.
- Study timelines and visits: The study will last 2 weeks. The study requires 5 visits.